z-logo
open-access-imgOpen Access
Childhood Asthma and Covid 19
Author(s) -
O. U. Soyer
Publication year - 2020
Publication title -
asthma allergy immunology
Language(s) - English
Resource type - Journals
ISSN - 1308-9234
DOI - 10.21911/aai.561
Subject(s) - medicine , asthma , exacerbation , cytokine storm , comorbidity , covid-19 , pandemic , immunosuppression , immunology , disease , asthma exacerbations , coronavirus , intensive care medicine , infectious disease (medical specialty)
Coronavirus disease 2019 (Covid 19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV 2) and causes lymphopenia, immunosuppression, inefficient T and B cell immunity, cytokine storm, and destructive tissue inflammation Since COVID 19 is a multi-system disease predominantly affecting the lungs, there is doubt on whether chronic lung diseases place patients at higher risk and SARS CoV2 leads to asthma exacerbation None of the studies have reported asthma or recurrent wheezing as a comorbidity or risk factor for Covid 19 in children up to now Notably, further studies are needed to explore the relationship between Covid 19 and asthma to improve clinical practice and decrease morbidity and mortality

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom